Clinical Trials Browser

Phase NA × Recruiting × Lymphoma, B-Cell, Marginal Zone × Clear all

Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Motor Activity, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone

NCT04097067 2024-08-27

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

Phase NA Recruiting

83 enrolled

Lymphoid

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT06478472 2024-07-29

Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy

Phase NA Recruiting

36 enrolled

Lymphoid

Lymphoma, B-Cell, Marginal Zone

Clinical Trials

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma

Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy